# A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer

> **NCT05361902** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 35 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Adaptive radiotherapy according to UPRATE protocol

## Key facts

- **NCT ID:** NCT05361902
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-07-07
- **Primary completion:** 2024-06-13
- **Final completion:** 2027-02
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05361902

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05361902, "A First Step Towards Ultra-hypofractionation for Unfavourable Intermediate and High-risk Prostate Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05361902. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*